Details for New Drug Application (NDA): 208562
✉ Email this page to a colleague
The generic ingredient in VORICONAZOLE is voriconazole. There are fourteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the voriconazole profile page.
Summary for 208562
Tradename: | VORICONAZOLE |
Applicant: | Xellia Pharms Aps |
Ingredient: | voriconazole |
Patents: | 0 |
Suppliers and Packaging for NDA: 208562
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VORICONAZOLE | voriconazole | INJECTABLE;INTRAVENOUS | 208562 | NDA | XGen Pharmaceuticals DJB, Inc. | 39822-1077 | 39822-1077-1 | 1 VIAL, SINGLE-DOSE in 1 CARTON (39822-1077-1) / 20 mL in 1 VIAL, SINGLE-DOSE |
VORICONAZOLE | voriconazole | INJECTABLE;INTRAVENOUS | 208562 | NDA | Xellia Pharmaceuticals USA LLC | 70594-067 | 70594-067-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70594-067-01) / 20 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 200MG/VIAL | ||||
Approval Date: | Mar 9, 2017 | TE: | AP | RLD: | No |
Complete Access Available with Subscription